NO970477L - Inhibisjon av leukotrien biosyntese med ureaderivater - Google Patents

Inhibisjon av leukotrien biosyntese med ureaderivater

Info

Publication number
NO970477L
NO970477L NO970477A NO970477A NO970477L NO 970477 L NO970477 L NO 970477L NO 970477 A NO970477 A NO 970477A NO 970477 A NO970477 A NO 970477A NO 970477 L NO970477 L NO 970477L
Authority
NO
Norway
Prior art keywords
leukotriene biosynthesis
inhibition
urea derivatives
compound
pharmaceutical composition
Prior art date
Application number
NO970477A
Other languages
English (en)
Other versions
NO970477D0 (no
NO315786B1 (no
Inventor
Stephen L Crooks
Bryon A Merrill
Paul D Wightman
Original Assignee
Minnesota Mining & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/455,643 external-priority patent/US5612377A/en
Application filed by Minnesota Mining & Mfg filed Critical Minnesota Mining & Mfg
Publication of NO970477D0 publication Critical patent/NO970477D0/no
Publication of NO970477L publication Critical patent/NO970477L/no
Publication of NO315786B1 publication Critical patent/NO315786B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
NO19970477A 1994-08-04 1997-02-03 Inhibisjon av leukotrienbiosyntese med ureaderivater NO315786B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28601794A 1994-08-04 1994-08-04
US08/455,643 US5612377A (en) 1994-08-04 1995-05-31 Method of inhibiting leukotriene biosynthesis
PCT/US1995/007667 WO1996003983A1 (en) 1994-08-04 1995-07-14 Inhibition of leukotriene biosynthesis with urea derivatives

Publications (3)

Publication Number Publication Date
NO970477D0 NO970477D0 (no) 1997-02-03
NO970477L true NO970477L (no) 1997-03-14
NO315786B1 NO315786B1 (no) 2003-10-27

Family

ID=26963530

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19970477A NO315786B1 (no) 1994-08-04 1997-02-03 Inhibisjon av leukotrienbiosyntese med ureaderivater

Country Status (19)

Country Link
EP (1) EP0777471B1 (no)
JP (1) JPH10503771A (no)
AT (1) ATE228359T1 (no)
AU (1) AU685980B2 (no)
BR (1) BR9508521A (no)
CA (1) CA2196701A1 (no)
CZ (1) CZ287034B6 (no)
DE (1) DE69528984T2 (no)
DK (1) DK0777471T3 (no)
ES (1) ES2185708T3 (no)
FI (1) FI970452A0 (no)
HU (1) HUT76830A (no)
IL (1) IL114646A (no)
NO (1) NO315786B1 (no)
NZ (1) NZ290236A (no)
PL (1) PL180668B1 (no)
PT (1) PT777471E (no)
SK (1) SK282777B6 (no)
WO (1) WO1996003983A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6126919A (en) 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
FR2880022B1 (fr) * 2004-12-24 2007-08-24 Mayoly Spindler Soc Par Action Nouveaux derives de la n-hydroxy-n'-phenyluree et de la n-hydroxy-n'-phenylthiouree et leur utilisation comme inhibiteurs de la synthese de la melanine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5066658A (en) * 1988-11-10 1991-11-19 Ortho Pharmaceutical Corporation Substituted hydroxyureas
CA2046872A1 (en) * 1989-02-01 1990-08-02 Dee W. Brooks Lipoxygenase inhibiting compounds
JP2528741B2 (ja) * 1991-01-09 1996-08-28 ファイザー製薬株式会社 オキサゾ―ル、チアゾ―ルおよびイミダゾ―ル化合物

Also Published As

Publication number Publication date
DE69528984T2 (de) 2003-09-04
CZ287034B6 (en) 2000-08-16
IL114646A0 (en) 1995-11-27
HUT76830A (en) 1997-11-28
NO970477D0 (no) 1997-02-03
MX9700860A (es) 1997-10-31
ES2185708T3 (es) 2003-05-01
WO1996003983A1 (en) 1996-02-15
EP0777471A1 (en) 1997-06-11
PL180668B1 (pl) 2001-03-30
ATE228359T1 (de) 2002-12-15
JPH10503771A (ja) 1998-04-07
IL114646A (en) 2000-02-29
EP0777471B1 (en) 2002-11-27
CZ31297A3 (en) 1997-09-17
DK0777471T3 (da) 2003-03-17
AU685980B2 (en) 1998-01-29
SK282777B6 (sk) 2002-12-03
AU3091795A (en) 1996-03-04
FI970452A (fi) 1997-02-03
DE69528984D1 (de) 2003-01-09
NZ290236A (en) 1998-12-23
SK11097A3 (en) 1997-09-10
PT777471E (pt) 2003-04-30
NO315786B1 (no) 2003-10-27
FI970452A0 (fi) 1997-02-03
CA2196701A1 (en) 1996-02-15
BR9508521A (pt) 1997-10-28
PL318539A1 (en) 1997-06-23

Similar Documents

Publication Publication Date Title
ATE203515T1 (de) Meta-substituierte phenylsulphonamidderivate
BR0212042A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto
IL136044A (en) 2-aminoacetamide derivatives and pharmaceutical compositions containing the same
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
CA2216796A1 (en) Quinazoline derivatives
YU69902A (sh) Novi derivati piperazina
DK0889875T3 (da) Cycloproylalkansyrederivater
TR199700844T1 (xx) Pirazolil-Benzoil T�revleri.
BG103947A (en) Derivatives of 9-oxymerythromycin
MX9708452A (es) Inhibidores de sialidasa bacteriana y metodos para fabricar y usar la misma.
NO960632D0 (no) Nye bis-naftalimider for behandling av kreft
DE60005517D1 (de) Kaliumkanal-blockierende mittel
DE69330601D1 (de) Serotoninergische ergolin derivate
NO970477L (no) Inhibisjon av leukotrien biosyntese med ureaderivater
AP9801235A0 (en) Erythromycin derivatives.
ATE94050T1 (de) Mittel zur verhinderung von zahnbelagbildung.
WO1995022544A3 (de) Substituierte 1,3,8-triaza-spiro(4,5)-decan-4-on-derivate als vorstufen zur herstellung von pharmazeutika
AR015458A1 (es) Compuestos de tetrahidrofurano, y composicion farmaceutica que lo contiene.
DK1264836T3 (da) Fremgangsmåde til fremstilling af indolopyrrolocarbaxolderivater
PT971714E (pt) Metodo utilizando inibidores ciclooxigenase-2 no tratamento e prevencao da demencia